Distinct Inflammatory Th17 Subsets Emerge in Autoimmunity and Infection

Investigators demonstrated that the inflammatory Th17 cells involved in autoimmune colitis and those activated during colitogenic infection were distinguishable populations characterized by their differential responses to the pharmacological molecule, clofazimine.